Trial Profile

A Single/Multiple Ascending Dose Phase 1 Study of the Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Human Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BT 200 (Primary) ; BT 200 (Primary) ; BT 200 (Primary) ; Desmopressin
Indications Atherosclerosis; Stroke
Focus Adverse reactions; First in man
Sponsors Band Therapeutics

Most Recent Events

17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association
21 Sep 2020 Status changed from active, no longer recruiting to completed.
10 Jul 2020 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com